18.04.2022 - 20.04.2022Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, USA
Time: 08:30 - 16:10
Temas de la conferencia Since 2019, venture capitalists have been predicting a "golden era of neuroscience products" and successes of "radical new breakthrough therapies" in the notoriously challenging space.
Now, three years on, 2022 is hosting the neuroscience renaissance and pharma is doubling down to understand the neuropathological and neuroprotective role of neuroinflammation as the most promising opportunity to bring more targeted, precise and transformative therapies
Speakers: Alejandro Rangel, Applied Neurosciences Department Head, Mexican Council of Neuroscience, Andrea Crotti, Principal Scientist, Takeda Pharmaceutical and more.
